Chuka University’s John Tingoi to Represent Kenya at Global Quant Championship Finals
African News

Chuka University’s John Tingoi to Represent Kenya at Global Quant Championship...

Shitemi - 0
Uganda signs deal to temporarily host asylum seekers rejected by Netherlands
WORLD

Uganda signs deal to temporarily host asylum seekers rejected by Netherlands

Dan Mughogho - 0
Chelsea Fans Celebrate João Pedro’s 24th Birthday Ahead of Brighton Clash
Sports

Chelsea Fans Celebrate João Pedro’s 24th Birthday Ahead of Brighton Clash

Shitemi - 0
Governor Wanga Accuses Kalonzo of Disrespecting Raila
Politics

Governor Wanga Accuses Kalonzo of Disrespecting Raila

Shitemi - 0
IEBC Targets 6.3 Million New Voters Ahead of 2027 General Election
African News

IEBC Targets 6.3 Million New Voters Ahead of 2027 General Election

Shitemi - 0
Masaka Arrest Turns Chaotic as Suspect Bites Officer
POPULAR STORIES

Journalist Abducted and Assaulted in Homa Bay Over Job Scam Exposé

Shitemi - 0
US President Donald Trump said on Thursday that the US will impose 100% tariffs on imports of branded or innovative drugs starting from 1 October, despite setting a much lower ceiling with the EU earlier this year. So far, it’s unclear how exactly this will impact the EU. In a Truth Social post, Trump said that there is a catch: some exemptions will be granted to companies which have signalled that they will make new investments in manufacturing in the US. Some European drugmakers have already announced plans to do so – including Roche, Novartis, and AstraZeneca. This will be “defined as ‘breaking ground’ and/or ‘under construction’,” Trump wrote. “There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started.” In August, the EU and US agreed on a 15% flat tariff, exempting generics and tied to Washington’s Section 232 drug import investigation. Trump gave no legal basis for the levies. It’s also an escalation from when Trump previously announced that he would be slapping tariffs on EU pharmaceuticals up to 250%, giving companies around a year to relocate. EFPIA, the Brussels-based innovative pharma group, stressed that the EU and US “already have a trade agreement in place.” “They should now continue discussions on how the EU can improve its support towards the cost of global research and development in a way which doesn’t harm patients in the EU and the US,” added Nathalie Moll, EFPIA director general. Separately, Trump has been using the threat of tariffs to exert pressure on national governments to raise drug prices.
ENTERTAINMENT

Trump announces new round of drug tariffs, muddying EU-US trade deal

Dan Mughogho - 0
Presidential, legislative elections kick off in Seychelles
African News

Presidential, legislative elections kick off in Seychelles

Dan Mughogho - 0
25 years for murder of German tourist near Kruger National Park, South Africa
African News

25 years for murder of German tourist near Kruger National Park,...

Dan Mughogho - 0
Trump signs executive order supporting proposed deal to put TikTok under US ownership
WORLD

Trump signs executive order supporting proposed deal to put TikTok under...

Dan Mughogho - 0
1...147148149...416Page 148 of 416